Issues For Conducting Clinical Research During the COVID-19 PandemicOctober 2020
A timely research article in JMIR Public Health and Surveillance details considerations that Principal Investigators (PIs) must take into account when determining if and how to conduct participant visits for clinical research trials during the COVID-19 pandemic. The authors examine all aspects that can have an effect on participant visits, ranging from policy-related factors to workforce-related issues and research participant perspectives. Ultimately, the PI must evaluate the risk-benefit ratio to identify the best course of action, with a suggested decision tree for determining when to conduct in-person participant visits.
To see the results of our participant survey, click here
To read the JMIR Public Health and surveillance article, click here